Stay updated with breaking news from Applying Evidence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Closing out this discussion, experts share their final thoughts on advanced HCC treatments and key data presented at the 2023 ASCO Gastrointestinal Cancers Symposium.
Expert panelists highlight anti-angiogenic systemic therapies under investigation for advanced HCC in second line and beyond.
In the context of frontline treatment strategies in advanced HCC, expert oncologists review clinical research in systemic immunotherapy approaches.
- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering...